ALZN
Alzamend NeuroFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ALZN vs peer average
40/100
ALZN vs. peer average (F vs. D)
Grade spread
D 5 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
XBIO is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.64M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALZN
Alzamend Neuro
XBIO
Xenetic Biosciences
Grade
F
D
Momentum
18
63
Value
41
41
Sentiment
-
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs XBIO
ALZN / XBIO
Grade Position
Below peers
ALZN vs. peer average (F vs. D)
40/100
Momentum
18
XBIOValue
41
ALZNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALZN
XBIO is the first peer returned for this comparison set.

